Phase II Trials of Letermovir Prophylaxis in Patients With RRMM Undergoing Elranatamab Therapy
Clinical trial NCT06920251 · RECRUITING
Trial details
- NCT number
- NCT06920251
- Sponsor
- Seoul National University Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-11
- Primary completion
- 2027-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.